Determining medical decision-making capacity in brain tumor patients: why and how?

ABSTRACT:

Background

Brain tumor patients are at high risk of impaired medical decision-making capacity (MDC), which can be ethically challenging because it limits their ability to give informed consent to medical treatments or participation in research. The European Association of Neuro-Oncology Palliative Care Multidisciplinary Task Force performed a systematic review to identify relevant evidence with respect to MDC that could be used to give recommendations on how to cope with reduced MDC in brain tumor patients.

Methods

A literature search in several electronic databases was conducted up to September 2019, including studies with brain tumor and other neurological patients. Information related to the following topics was extracted: tools to measure MDC, consent to treatment or res

SUBMITTER: Pace A 

PROVIDER: S-EPMC7716185 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature